Literature DB >> 208953

Primary signet ring cell carcinoma of the breast.

M Harris, S Wells, K S Vasudev.   

Abstract

Three examples of primary signet ring cell carcinoma of the breast are described. This form of breast carcinoma deserves recognition as an entity because its prognosis may differ from colloid carcinoma of the breast and because of potential difficulty in distinguishing it from metastatic carcinoma.

Entities:  

Mesh：

Year:  1978        PMID： 208953     DOI： 10.1111/j.1365-2559.1978.tb01707.x

Source DB:  PubMed          Journal:  Histopathology        ISSN： 0309-0167            Impact factor:   5.087


  6 in total

1.  Mucinous breast carcinoma with tall columnar cells.

Authors:  N Tsoukalas; M Kiakou; M Tolia; I D Kostakis; M Galanopoulos; G Nakos; D Tryfonopoulos; G Kyrgias; G Koumakis
Journal:  Ann R Coll Surg Engl       Date:  2018-04-16       Impact factor: 1.891

2.  Primary signet ring cell carcinoma of the breast.

Authors:  J A Al-Hariri
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1980

3.  Metastatic Signet-Ring Cell Gastric Carcinoma Masquerading as Breast Primary.

Authors:  Dinesh Chandra Doval; Shripad Brahmanand Pande; Jai Bhagwan Sharma; Sameer Khatri; Arvind Kumar Khurana; Ashok Kumar Vaid; Arvind Kumar Chaturvedi; Digant Hazarika
Journal:  Case Rep Gastroenterol       Date:  2009-03-28

4.  Poorer Prognosis of Primary Signet-Ring Cell Carcinoma of the Breast Compared with Mucinous Carcinoma.

Authors:  Xiufeng Wu; Zhenzhen Zhang; Xin Li; Qingzhong Lin; Gang Chen; Jianping Lu; Yi Zeng; Dan Hu; Kai Huang; Zhiwu Lin; Jun Yan
Journal:  PLoS One       Date:  2016-09-01       Impact factor: 3.240

5.  Pure primary signet ring cell carcinoma breast: A rare cytological diagnosis.

Authors:  Jashan Sandhu; V K Dubey; Manisha Makkar; Vijay Suri
Journal:  J Cytol       Date:  2013-07       Impact factor: 1.000

6.  Signet-ring cell carcinoma of the breast: a case report.

Authors:  Xing Li; Yan-fen Feng; Wei-dong Wei; Peng Liu; Ze-ming Xie; Jin Wang; Xiao-ming Xie
Journal:  World J Surg Oncol       Date:  2013-08-09       Impact factor: 2.754
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.